We begin this edition of our newsletter with a new mice study that shows how changes related to aging in the gut microbiome mediate arterial dysfunction, while oxidative stress and inflammation are both normalized.
Next up, we cover a new cross-sectional study, which has found that interactions between the gut microbiota and bile acid metabolism may partially mediate the success of bariatric surgery in the medium term. You will also find a new study showing the adaptive behavior of the Escherichia coli Nissle probiotic in the mouse gut, opening new avenues for moving towards personalized probiotic medicine.
Finally, we have two new studies on the potential role of gut microbial signatures for predicting colorectal cancer (CRC), validated using whole-metagenome shotgun datasets across CRC cohorts from different countries.
The GMFH publishing team